To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-11-30

Study Completion Date

2015-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This survey is conducted in South America. The purpose is to identify the key psychosocial issues affecting patients with haemophilia.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Survey Evaluating the Psychosocial Effects of Living With Haemophilia

NCT01322620

Congenital Bleeding Disorder Haemophilia A Haemophilia B +3 more

COMPLETED

He-move-philia, Lifestyle Intervention for Patients With Hemophilia

NCT05608863

Hemophilia

ACTIVE_NOT_RECRUITING NA

National Survey of People With Haemophilia in Portugal

NCT02870114

Haemophilia

COMPLETED

Quality of Life and Adjustment Among Siblings of Children and Adolescents With Severe Hemophilia

NCT03299699

Severe Haemophilia

COMPLETED

Impact of Pain on Functional Impairment and Quality of Life in Adults With Hemophilia

NCT01988532

Congenital Bleeding Disorder Haemophilia A Haemophilia A With Inhibitors +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Congenital Bleeding Disorder Haemophilia A Haemophilia B Haemophilia A With Inhibitors Haemophilia B With Inhibitors Relatives to/Carers of Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

survey

No treatment given

Intervention Type OTHER

No treatment given. Participants are to complete a questionnaire in the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

No treatment given

No treatment given. Participants are to complete a questionnaire in the study.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men aged 18 years or above with haemophilia A or B (with or without inhibitors) OR Parents/caregivers of children/adolescents younger than 18 years with haemophilia A or B (with or without inhibitors); only one subject per household will be able to participate
* Patients currently receiving one of the following treatments: a. replacement factor VIII therapy, b. replacement factor IX therapy, c. bypassing agents (recombinant factor VIIa or APCC) OR Patients with haemophilia, not receiving any kind of treatment with replacement factor VIII or IX or a bypassing agent (as appropriate), but who have had at least one spontaneous haemorrhage into one or more joints within the last 12 months
* The participants (patients with haemophilia and parents/caregivers for patients under 18 years old) must be able to complete a paper questionnaire in order to participate in the study
* Providing informed consent before the start of any study-related activities

Exclusion Criteria

* Inability for the patients or parents/caregivers to understand and comply with verbal instructions, unless assisted by a member of the HTC (Haemophilia Treatment Center) or by a relative. (No other conditions were established for patients who cannot read or write to be able to participate in this study in addition to the need of help from a member of HTC or by a relative.)

Minimum Eligible Age

18 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No